Nicolas Bery

ORCID

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 10

Top Venues

Antibodies (Basel, Switzerland)

eLife

Nature communications

Proceedings of the National Academy of Sciences of the United States of America

Cancer Research Centre of Toulouse

Université de Toulouse (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Cancer Research Centre of Toulouse Mar 02 2020

France

Senior Postdoctoral Scientist

University of Oxford Apr 09 2015 - Feb 29 2020

United Kingdom

Postdoctoral Scientist :: MRC Molecular Haematology Unit

Education History

Université de Toulouse

France

PHD :: Cancer Research Center of Toulouse

Université de Toulouse

France

MSC :: Oncology

Publications

Marie Sorbara, Pierre Cordelier, Nicolas Bery
Antibody-Based Approaches to Target Pancreatic Tumours. Antibodies (Basel, Switzerland) 11 (3) (2022)
Marie Sorbara, Nicolas Bery
Targeting small GTPases and their downstream pathways with intracellular macromolecule binders to define alternative therapeutic strategies in cancer. Biochemical Society transactions 49 (5) (2022)
Nicolas Bery, Carole J R Bataille, Angela Russell, Angela Hayes, Florence I Raynaud, Sabine Milhas, Sneha Anand, Hanna Tulmin, Ami Miller, Terence Howard Rabbitts
A cell-based screening method using an intracellular antibody for discovering small molecules targeting the translocation protein LMO2. Science advances 7 (15) (2021)
Nicolas Bery, Ami Miller, Terence Howard Rabbitts
A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS. Nature communications 11 (1) (2020)
Helio Pais, Katia Ruggero, Jing Zhang, Osama Al-Assar, Nicolas Bery, Ravneet Bhuller, Victoria Weston, Pamela R Kearns, Cristina Mecucci, Ami Miller, Terence Howard Rabbitts
Surfaceome interrogation using an RNA-seq approach highlights leukemia initiating cell biomarkers in an LMO2 T cell transgenic model. Scientific reports 9 (1) (2019)
Abimael Cruz-Migoni, Peter Canning, Camilo E Quevedo, Carole J R Bataille, Nicolas Bery, Ami Miller, Angela J Russell, Simon E V Phillips, Stephen B Carr, Terence H Rabbitts
Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds. Proceedings of the National Academy of Sciences of the United States of America 116 (7) (2019)
Laura Keller, Nicolas Bery, Claudine Tardy, Laetitia Ligat, Gilles Favre, Terence Howard Rabbitts, Aurélien Olichon
Selection and Characterization of a Nanobody Biosensor of GTP-Bound RHO Activities. Antibodies (Basel, Switzerland) 8 (1) (2019)
Nicolas Bery, Abimael Cruz-Migoni, Carole Jr Bataille, Camilo E Quevedo, Hanna Tulmin, Ami Miller, Angela Russell, Simon Ev Phillips, Stephen B Carr, Terence Howard Rabbitts
BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions. eLife 7 (2018)
Sandrine Guillard, Paulina Kolasinska-Zwierz, Judit Debreczeni, Jason Breed, Jing Zhang, Nicolas Bery, Rose Marwood, Jon Tart, Ross Overman, Pawel Stocki, Bina Mistry, Christopher Phillips, Terence Rabbitts, Ronald Jackson, Ralph R Minter
Structural and functional characterization of a DARPin which inhibits Ras nucleotide exchange. Nature communications 8 (2017)
Sandrine Moutel, Nicolas Bery, Virginie Bernard, Laura Keller, Emilie Lemesre, Ario de Marco, Laetitia Ligat, Jean-Christophe Rain, Gilles Favre, Aurélien Olichon, Franck Perez
NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies. eLife 5 (2016)

Nicolas Bery.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Nicolas Bery